RSS Feeds
Cholesterol Reduction and Stroke
- George Davey Smith, MD;
- Matthias Egger, MD; and
- Trevor A. Sheldon, MSc
- University of Glasgow; Glasgow G12 8RZ; Scotland University of Berne; CH-3012 Berne; Switzerland University of York; York; United Kingdom
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Atkins and colleagues' meta-analysis [1] of stroke in randomized controlled trials of cholesterol reduction shows the problems inherent in this technique. The first is publication bias; unpublished studies may have systematically …
This 100-word excerpt has been provided in the absence of an abstract.
